Abstract: An amorphous form of imipramine pamoate, morphologically pure forms, and mixtures of amorphous and morphologically pure imipramine pamoate characterized by differential scanning calorimetry, fourier transform infrared, and powder x-ray diffraction, and pharmaceutical compositions formed therefrom.
Type:
Grant
Filed:
November 10, 2006
Date of Patent:
May 18, 2010
Assignee:
Pisgah Labs, Inc.
Inventors:
Clifford Riley King, David William Bristol, Vicki Haynes Audia, Joseph Pike Mitchener, Jr.